International Journal of Particle Therapy
Scope & Guideline
Transforming Patient Outcomes Through Cutting-edge Research
Introduction
Aims and Scopes
- Clinical Applications of Particle Therapy:
The journal emphasizes research on the clinical applications of proton and carbon ion therapies across various cancer types, assessing their effectiveness and safety compared to traditional photon therapies. - Radiobiological Studies:
It investigates the radiobiological mechanisms underlying particle therapy, exploring how different radiation types affect tumor and normal tissue responses. - Technological Innovations and Methodologies:
The journal covers advancements in treatment planning, delivery techniques, and imaging methods that enhance the precision and efficacy of particle therapy. - Patient Outcomes and Quality of Life:
Research on long-term patient outcomes, including survivorship, quality of life, and toxicity profiles associated with particle therapy, is a core focus. - Health Economics and Accessibility:
The journal also addresses the economic aspects of particle therapy, including cost-effectiveness analyses and accessibility issues for patients.
Trending and Emerging
- Artificial Intelligence and Machine Learning in Treatment Planning:
There is a growing trend towards integrating artificial intelligence and machine learning techniques in treatment planning and optimization for particle therapy, highlighting the role of technology in enhancing precision and outcomes. - Personalized Medicine Approaches:
Research is increasingly focusing on personalized medicine, tailoring particle therapy based on individual patient characteristics and tumor biology to improve treatment efficacy. - Longitudinal Studies on Outcomes and Toxicity:
Emerging studies are emphasizing long-term follow-up and the assessment of late toxicities associated with particle therapy, indicating a shift towards understanding the long-term impacts of treatments. - Combination Therapies:
There is a rising interest in exploring combination therapies that integrate particle therapy with immunotherapy, chemotherapy, or targeted therapies, aiming for synergistic effects in cancer treatment. - Patient-Centered Care and Quality of Life Studies:
Research focusing on patient-centered outcomes, including quality of life assessments and patient-reported outcomes, is becoming increasingly prominent, reflecting a holistic approach to cancer care.
Declining or Waning
- Traditional Radiotherapy Comparisons:
Research comparing particle therapy with traditional photon therapies has decreased, possibly due to a growing consensus on the advantages of particle therapies, leading to less need for comparative studies. - Non-oncological Applications:
There has been a noticeable decline in studies focusing on non-oncological applications of particle therapy, such as its use in benign conditions, which may have been overshadowed by more pressing oncological research. - Earlier Historical Perspectives:
Papers focusing on historical reviews of particle therapy have become less common, as the field moves towards more contemporary and forward-looking research.
Similar Journals
Turk Onkoloji Dergisi-Turkish Journal of Oncology
Connecting researchers to transform cancer treatment and prevention.Turk Onkoloji Dergisi - Turkish Journal of Oncology, published by KARE PUBL, serves as a vital platform in the field of oncology, specifically catering to the Turkish-speaking research community and contributing to global discourse. With an ISSN of 1300-7467, this journal, which has been in circulation since 2007 and continues until 2024, recognizes the importance of advancing medical knowledge in cancer research through rigorous peer-reviewed articles. Although currently positioned in the Q4 category of oncology journals with a Scopus rank of #344 out of 404, the journal is dedicated to fostering significant research insights and innovative perspectives on cancer treatment and prevention. While it does not currently offer open access, its content is essential for professionals, researchers, and students aiming to enhance their understanding of oncology developments in Turkey and beyond. The Turkish Journal of Oncology not only aspires to improve the quality of cancer care but also strives to enhance collaboration among researchers, thereby influencing future oncology practices.
Journal of Medical Imaging and Radiation Oncology
Advancing the Frontiers of Medical Imaging and OncologyJournal of Medical Imaging and Radiation Oncology, published by WILEY, is a pivotal resource in the fields of oncology and medical imaging. With an impact factor reflective of its commitment to advancing research, the journal has maintained a robust reputation since its inception in 2008 and continues to thrive through 2024. It is indexed with an insightful ranking, with a Q2 classification in Radiology, Nuclear Medicine and Imaging, affirming its importance in these disciplines. This journal not only serves as an open access platform, allowing extensive reach and accessibility, but also fosters a scholarly community dedicated to the innovation of imaging techniques and radiation oncology practices. As a key player in disseminating crucial findings and advancements, it appeals to researchers, clinicians, and students who aim to contribute to the evolving landscape of medical imaging and cancer treatment methodologies. The journal is based in Australia, at 111 River St, Hoboken, NJ, and invites submissions that push the boundaries of current knowledge in this critical area of healthcare.
Radiological Physics and Technology
Pioneering discoveries in medical imaging.Radiological Physics and Technology, published by SPRINGER JAPAN KK, is a prominent journal that serves as a crucial resource in the multidisciplinary fields of medicine and radiation sciences. With an ISSN of 1865-0333 and an E-ISSN of 1865-0341, the journal has been converging impactful research from 2008 to 2024. It holds a commendable position in academic rankings, currently classified in Q2 in Physical Therapy, Sports Therapy and Rehabilitation and Radiation, along with Q3 for Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging. The journal is well-regarded in the academic community, reflected in its Scopus rankings that place it in the upper tiers of its respective categories. Although it currently does not offer Open Access, Radiological Physics and Technology remains a pivotal publication for researchers, academics, and practitioners seeking to advance knowledge and foster innovation in radiological science. Its commitment to disseminating high-quality research ensures its continued relevance and importance within these fields.
EPJ Techniques and Instrumentation
Advancing instrumentation for a brighter scientific future.EPJ Techniques and Instrumentation is a leading journal published by Springer that focuses on advancing the field of instrumentation and measurement techniques across various disciplines. With a commitment to open access since 2014, this journal ensures that the latest research is freely available to academics, providing an inclusive platform for the dissemination of innovative methodologies and technological advancements. The journal serves as an essential resource for researchers, professionals, and students dedicated to the development and application of cutting-edge techniques in their respective fields. While the journal's scope encompasses a wide range of topics, it consistently encourages interdisciplinary collaboration and the exchange of ideas. As a cornerstone publication in the scientific community, EPJ Techniques and Instrumentation is poised to impact the trajectory of future research, fostering a deeper understanding and better utilization of instrumentation in scientific inquiry.
Advances in Radiation Oncology
Empowering Oncology through Open Access InsightsAdvances in Radiation Oncology, published by Elsevier Inc, is a premier international journal dedicated to the field of oncology and radiology, focusing on the latest groundbreaking research and innovations in radiation therapy. Launched as an Open Access journal in 2016, it has since carved out a significant niche in the academic community, featuring contributions that span a diverse range of topics including clinical practices, technologies, and outcomes in radiation oncology. With an impressive Q2 rankingOncology and Radiology, Nuclear Medicine and Imaging categories for 2023, and positioned within the 65th and 55th percentiles of Scopus ranks, it serves as an essential resource for researchers, medical professionals, and students alike. The journal not only emphasizes the importance of disseminating knowledge widely through its open access model but also aims to foster collaboration and innovation in the evolving landscape of cancer treatment. For those looking to stay at the forefront of radiotherapy research and advancements, Advances in Radiation Oncology is an invaluable platform for scholarly communication.
MEDICAL PHYSICS
Navigating the Future of Healthcare Through Scientific InquiryMEDICAL PHYSICS, published by WILEY, stands as a leading journal in the fields of biophysics, medicine, and radiology, boasting an impressive impact factor and classified within the prestigious Q1 category across multiple relevant domains. With its ISSN 0094-2405 and E-ISSN 2473-4209, the journal has been a vital resource since its inception in 1974, leading the discourse well into 2024. Hailing from the United States, MEDICAL PHYSICS serves a diverse academic audience, comprising researchers, clinicians, and students eager to engage with the latest advancements and methodologies. The journal’s authoritative presence is underscored by its Scopus rankings, placing it among the top percentile in both Medicine and Biophysics, marking it as an essential scholarly platform for innovative research and critical reviews. While not currently an Open Access journal, its commitment to curating high-quality articles ensures that readers can access groundbreaking insights into medical imaging, treatment protocols, and the theoretical underpinnings of medical physics. Explore the intersection of technology and healthcare through the esteemed pages of MEDICAL PHYSICS.
RADIOTHERAPY AND ONCOLOGY
Shaping the future of cancer treatment through peer-reviewed excellence.Radiotherapy and Oncology is a leading peer-reviewed journal published by Elsevier Ireland Ltd, focusing on the vital fields of hematology, oncology, and radiology. With an impressive impact factor and ranking in the top quartiles (Q1) of its categories as of 2023, it is recognized for disseminating high-quality research that contributes significantly to advancements in cancer treatment and patient care. The journal, which has been in circulation since 1983, aims to provide a platform for original research articles, reviews, and clinical studies that explore the latest innovations in radiotherapeutic technologies and oncology practices. This journal is essential for researchers, healthcare professionals, and students who are dedicated to improving cancer therapies and outcomes. Although it does not offer open access, the wealth of information contained within its pages supports continued education and development in these crucial medical fields.
PHYSICS IN MEDICINE AND BIOLOGY
Transforming Diagnostics and Therapies with PhysicsPHYSICS IN MEDICINE AND BIOLOGY is a prestigious journal published by IOP Publishing Ltd, with a storied history dating back to 1956 and extending through 2024. This internationally recognized journal caters to the interdisciplinary fields of medical physics and bioengineering, making significant contributions to the research and development of advanced diagnostic and therapeutic technologies. It holds an impressive Q1 ranking in both Radiological and Ultrasound Technology and Radiology, Nuclear Medicine and Imaging categories, reflecting its critical role in disseminating high-quality research. With a significant focus on merging the principles of physics with advancements in medicine, PHYSICS IN MEDICINE AND BIOLOGY serves as an essential resource for researchers, professionals, and students alike, fostering innovation and enhancing collaboration in the healthcare sector. Although the journal is not currently open access, it maintains robust participation in the Scopus database, ranking #62 out of 333 in Radiology, Nuclear Medicine and Imaging and #17 out of 63 in Radiological and Ultrasound Technology, signifying its influence and reach within these disciplines.
Radiation Oncology Journal
Advancing cancer care through innovative radiation research.Radiation Oncology Journal, published by the Korean Society of Therapeutic Radiology & Oncology, stands at the forefront of cancer treatment research and innovation within the dynamic fields of oncology and radiology. With a focus on disseminating groundbreaking findings and advancements from 2012 to 2024, this journal aims to foster collaboration among researchers, clinicians, and educators dedicated to improving therapeutic techniques and patient outcomes in the context of radiation therapy. Recognized with a prestigious Q2 ranking in both the Oncology and Radiology, Nuclear Medicine and Imaging categories, it ranks 140th out of 333 in its Scopus category for Medicine Radiology and boasts a 58th percentile placement. While operating on a non-open access basis, the journal remains committed to providing valuable insights and updates to professionals in the field from its base in South Korea. As the landscape of cancer treatment evolves, the Radiation Oncology Journal continues to play a vital role in shaping research trends and enhancing the understanding of radiotherapy's role in comprehensive cancer care.
Translational Oncology
Connecting Science and Clinical Practice in Cancer CareTranslational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.